Login / Signup

Case of harlequin ichthyosis with a favorable outcome: Early treatment and novel, differentially expressed, alternatively spliced transcripts of the ATP-binding cassette subfamily A member 12 gene.

Ken WashioMayuko SumiKaori NakataAtsushi FukunagaKeiji YamanaTsubasa KodaIchiro MoriokaChikako NishigoriKiyofumi Yamanishi
Published in: The Journal of dermatology (2017)
Harlequin ichthyosis (HI) is the most severe form of autosomal recessive congenital ichthyosis, with a high mortality rate. Recent advances in neonatal care and the early administration of retinoids have improved the survival rate of HI. Here, we present a case of HI who was successfully treated with early administration of etretinate and showed good prognosis. Next-generation sequencing identified novel mutations of the ATP-binding cassette subfamily A member 12 gene (ABCA12), c.5884+4_+5delAA and c.7239G>A, which caused skipping of exons 39 and 48, respectively. Transcripts with exon 48 skipping, which cause a deletion in the second ATP-binding cassette of ABCA12, were dominantly expressed in the skin. Besides the early administration of etretinate, the differential expression of the mutant protein with limited segmental deletion of ABCA12 may be related to the favorable outcome of our patient.
Keyphrases
  • copy number
  • healthcare
  • genome wide identification
  • binding protein
  • genome wide
  • palliative care
  • case report
  • early onset
  • intellectual disability
  • quality improvement
  • transcription factor
  • protein protein